Ontario’s COVID-19 Genomics Rapid Response Coalition
To accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario and to help expedite patient genome sequencing through a coordinated approach bringing together all of the province’s genomics resources and capacity to enable timely and comprehensive genomic analysis.
Standardized Sequencing Methodologies
Data Management & Sharing
The ON-CoV Coalition is designed to provide for method standardization and coordination of:
Collecting Patient Samples and Metadata
Data Curation and Management
This work will expedite real-time testing and reporting to inform public health and public policy, help manage and overcome the ongoing COVID-19 crisis and ensure scalability for Ontario’s future pandemics preparedness.
Genomic technologies are the foundation for the solutions necessary to combat the ongoing COVID-19
pandemic. Ontario’s world-leading expertise in genomics, bioinformatics, genomics epidemiology, and artificial intelligence, can expedite Ontario’s response to COVID-19.
The results reported by the Coalition will inform vaccine and therapeutic development.
Why Ontario Genomics?
Over the past 20 years, Ontario Genomics, together with the Ontario Government, Genome Canada, and academic, clinical and industry partners, has built a world-leading genomics ecosystem in Ontario with over $2.7B in funding leveraged for research, translation and the establishment of genomic technology platforms.
Ontario Genomics is well-positioned to provide and promote:
ONCoV Genomics Coalition Steering Committee
Dr. Herveen Sachdeva, Toronto Public Health
Dr. Sarah Wootton, University of Guelph
ONCoV Genomics Coalition Members
University of Toronto
Sunnybrook Health Sciences / University of Toronto
Health Sciences North
Dalla Lana School of Public Health, University of Toronto
Public Health Ontario
Sinai Health Systems
Hospital for Sick Children / University of Toronto
TCAG / CGEn
Kingston Health Sciences Centre / Queen’s University
Ontario Institute for Cancer Research
Unity Health Toronto / University of Toronto
Peter Munk Cardiac Centre, UHN / University of Toronto
University of Guelph
We are proactively working with the research community, partner genome centres, and governments to accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario. Learn more and stay up-to-date about our COVID-19 programs and important resources.
2 years into the pandemic, burning questions remain about COVID-19 — and how we fight it
March 11, 2022
Two years into the pandemic, questions remain about COVID-19 and how we fight it. Scientists like Dr. Samira Mubareka, part of the first Canadian research team to isolate SARS-CoV-2 and study its genetics are striving to unpack what makes this unique pathogen tick. We’re honoured to have Dr. Mubareka as an impactful member of our ONCoV initiative.
Plan for testing after N.B. lifts COVID-19 restrictions remains unclear
March 1, 2022
As restrictions end, there is "absolutely" the risk another wave could be on the way with the new BA2 subvariant of the Omicron variant spreading in Canada, said Dr. Allison McGeer, infectious disease physician at Sinai Health System in Toronto and a member of our ONCoV initiative.
The good and bad news on Omicron subvariant BA.2 as it continues to spread in Ontario
February 24, 2022
The good and bad news on the Omicron subvariant BA.2 as it continues to spread in Ontario - “Even though we’re all concerned about this Omicron subvariant, I think there are reasons to be optimistic,” said Catalina Lopez-Correa, CSO at Genome Canada leading CanCOGeN, which Ontario Genomics actively supports.